A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab

Eleonora Nucera; Fabio Basta; Alessandro Buonomo; Simona Mezzacappa; D. P. Margiotta; R. Antonelli Incalzi; Raffaele Antonelli Incalzi; Domenico Schiavino

doi:10.18176/jiaci.0191

A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab

Eleonora Nucera
, Fabio Basta
, Alessandro Buonomo
, Simona Mezzacappa
, D. P. Margiotta
, R. Antonelli Incalzi
, Raffaele Antonelli Incalzi
, Domenico Schiavino

Università Cattolica del Sacro Cuore

Universita Campus Bio-Medico di Roma

Risultato della ricerca: Contributo in rivista › Articolo

10 Citazioni (Scopus)

Abstract

Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare small-vessel vasculitis of unknown etiology first described by McDuffie We hypothesize that omalizumab is safe and effective in milder forms of HUVS, but not in those involving the kidney and/or the lung, which usually require immunosuppressive drugs

Lingua originale	Inglese
pagine (da-a)	382-384
Numero di pagine	3
Rivista	Journal of Investigational Allergology and Clinical Immunology
DOI	https://doi.org/10.18176/jiaci.0191
Stato di pubblicazione	Pubblicato - 2017

Keywords

Chronic urticarial
HUVS
Hypocomplementemic urticarial vasculitis syndrome
Lupus
Omalizumab

Accesso al documento

10.18176/jiaci.0191

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{31653dcdac2d410388f1b1f0bb939b6a,

title = "A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab",

abstract = "Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare small-vessel vasculitis of unknown etiology first described by McDuffie We hypothesize that omalizumab is safe and effective in milder forms of HUVS, but not in those involving the kidney and/or the lung, which usually require immunosuppressive drugs",

keywords = "Chronic urticarial, HUVS, Hypocomplementemic urticarial vasculitis syndrome, Lupus, Omalizumab, Chronic urticarial, HUVS, Hypocomplementemic urticarial vasculitis syndrome, Lupus, Omalizumab",

author = "Eleonora Nucera and Fabio Basta and Alessandro Buonomo and Simona Mezzacappa and Margiotta, \{D. P.\} and \{Antonelli Incalzi\}, R. and \{Antonelli Incalzi\}, Raffaele and Domenico Schiavino",

year = "2017",

doi = "10.18176/jiaci.0191",

language = "English",

pages = "382--384",

journal = "Journal of Investigational Allergology and Clinical Immunology",

issn = "1018-9068",

publisher = "Esmon",

}

TY - JOUR

T1 - A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab

AU - Nucera, Eleonora

AU - Basta, Fabio

AU - Buonomo, Alessandro

AU - Mezzacappa, Simona

AU - Margiotta, D. P.

AU - Antonelli Incalzi, R.

AU - Antonelli Incalzi, Raffaele

AU - Schiavino, Domenico

PY - 2017

Y1 - 2017

N2 - Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare small-vessel vasculitis of unknown etiology first described by McDuffie We hypothesize that omalizumab is safe and effective in milder forms of HUVS, but not in those involving the kidney and/or the lung, which usually require immunosuppressive drugs

AB - Hypocomplementemic urticarial vasculitis syndrome (HUVS) is a rare small-vessel vasculitis of unknown etiology first described by McDuffie We hypothesize that omalizumab is safe and effective in milder forms of HUVS, but not in those involving the kidney and/or the lung, which usually require immunosuppressive drugs

KW - Chronic urticarial

KW - HUVS

KW - Hypocomplementemic urticarial vasculitis syndrome

KW - Lupus

KW - Omalizumab

KW - Chronic urticarial

KW - HUVS

KW - Hypocomplementemic urticarial vasculitis syndrome

KW - Lupus

KW - Omalizumab

UR - http://hdl.handle.net/10807/120188

U2 - 10.18176/jiaci.0191

DO - 10.18176/jiaci.0191

M3 - Article

SN - 1018-9068

SP - 382

EP - 384

JO - Journal of Investigational Allergology and Clinical Immunology

JF - Journal of Investigational Allergology and Clinical Immunology

ER -

A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab

Abstract

Keywords

Accesso al documento

Altri file e collegamenti

Fingerprint

Cita questo